CNR1 and Alzheimer disease: The analysis of human postmortem samples of AD patients showed a decrease in the number of CB1-positive neurons in the frontal cortex in areas with amyloid plaques and activated microglial cells, as well as alterations of CB1 coupling to G proteins mediating its intracellular signaling [20,21].